---
title: "Vivo Bio Tech Ltd (511509) — Share Price, Financials & Analysis"
symbol: "511509"
company: "Vivo Bio Tech Ltd"
canonical: "https://tapetide.com/stocks/511509"
isin: "INE380K01017"
nse_symbol: "VIVOBIOT"
bse_code: "511509"
sector: "Healthcare"
industry: "Biotechnology"
market_cap_cr: 36.79
generated_at: "2026-09-13T18:26:28.239Z"
---

# Vivo Bio Tech Ltd (511509)

Canonical page: https://tapetide.com/stocks/511509

## Company

- **NSE Symbol:** VIVOBIOT
- **BSE Code:** 511509
- **ISIN:** INE380K01017
- **Sector:** Healthcare
- **Industry:** Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2026-08-17
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** vivobio.com

## About

Incorporated in 1987, Vivo Bio Tech 
Ltd is engaged in service of CRO offering 
Drug Development & Discovery Services 
to Pharmaceutical & Biotech Companies[1]

## Latest Price

- **Price:** ₹17.13
- **Change:** +0.14 (+0.82%)
- **Open:** ₹17
- **Day High:** ₹17.37
- **Day Low:** ₹16.5
- **Previous Close:** ₹16.99
- **Volume:** 33194
- **As Of:** 2026-09-11T10:20:00+00:00

## Key Fundamentals

Observed at 2026-09-11T04:47:43.829261Z.

- **Market Cap:** ₹36.79 Cr
- **Classification:** Microcap
- **P/E (reported):** -13.2
- **EPS (TTM):** ₹-1.28
- **Book Value:** ₹41.25
- **Price to Book:** 0.41
- **Dividend Yield:** 0%
- **ROE:** 9.35%
- **ROCE:** 14.12%
- **Debt to Equity:** 0.72
- **Revenue (yearly):** ₹53.33 Cr
- **Net Income:** ₹4 Cr
- **EBITDA:** ₹20.84 Cr
- **52-Week High:** ₹20.94
- **52-Week Low:** ₹16.75
- **RSI (14):** 26.88

## Tapetide Score

- **Score:** 40 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Falling
- **Percentile:** 14.5 (of 4473 scored stocks)
- **Confidence:** 93%
- **Data coverage:** 86%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 19.96 | 9% |
| growth | 54.45 | 9% |
| momentum | 13.71 | 12% |
| ownership | 34.53 | 24% |
| quality | 42.66 | 22% |
| valuation | 58.76 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.41 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -4.81%
- The company has delivered a poor sales growth of 0.59% over past five years.
- Promoter holding is low: 30.6%
- Company has a low return on equity of 2.24% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -23.78% | -20.23% | -16.57% |
| ebitda margin growth | 13.33% | -21.19% | -16.56% | 25.44% |
| net income growth | 103.85% | -45.21% | 60% | 81.82% |
| revenue growth | 0.7% | 3.55% | 1% | 1% |
| roce | -8.67% | 18.36% | 12.87% | 13.63% |
| roe | -103.68% | 101.51% | 6.37% | -30.01% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 9.26 | 12.85 | 11.76 | 10.13 | 12.04 | 12.21 | 12.29 | 12.51 | 13.11 | 13.51 | 14.2 | 14.28 |
| Expenses | 4.4 | 6.48 | 6.39 | 5.77 | 6.45 | 6.67 | 7.27 | 7.03 | 7.69 | 8.02 | 9.75 | 9.23 |
| Operating Profit | 4.86 | 6.37 | 5.37 | 4.36 | 5.59 | 5.54 | 5.02 | 5.48 | 5.42 | 5.49 | 4.45 | 5.05 |
| OPM % | 52.48 | 49.57 | 45.66 | 43.04 | 46.43 | 45.37 | 40.85 | 43.8 | 41.34 | 40.64 | 31.34 | 35.36 |
| Other Income | 0 | 0.03 | 0.01 | 0.01 | 4.63 | 0.01 | 0.15 | 0.14 | 0.13 | 0.14 | 0.03 | 0.06 |
| Interest | 2.09 | 2.22 | 1.52 | 1.92 | 2.06 | 1.84 | 1.68 | 1.5 | 1.47 | 1.4 | 1.48 | 1.24 |
| Depreciation | 2.3 | 2.28 | 2.43 | 2.23 | 2.29 | 2.25 | 2.25 | 2.64 | 2.57 | 2.66 | 2.75 | 3.53 |
| Profit before tax | 0.47 | 1.9 | 1.43 | 0.22 | 5.87 | 1.46 | 1.24 | 1.48 | 1.51 | 1.57 | 0.25 | 0.34 |
| Tax % | 29.79 | 31.05 | 48.95 | 27.27 | 10.73 | 43.84 | 14.52 | 9.46 | 42.38 | 20.38 | 2164 | 44.12 |
| Net Profit | 0.33 | 1.32 | 0.74 | 0.17 | 5.23 | 0.82 | 1.06 | 1.34 | 0.87 | 1.25 | -5.16 | 0.19 |
| EPS in Rs | 0.22 | 0.89 | 0.5 | 0.11 | 3.51 | 0.51 | 0.62 | 0.67 | 0.39 | 0.57 | -2.33 | 0.09 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 47 | 55.83 | 55.35 | 51.78 | 51.39 | 52.23 | 45.45 | 46.67 | 53.33 | 55.1 |
| Expenses | 36.11 | 46.32 | 42.88 | 33.98 | 35.3 | 30.39 | 24.19 | 26.11 | 32.48 | 34.69 |
| Operating Profit | 10.89 | 9.51 | 12.47 | 17.8 | 16.09 | 21.84 | 21.26 | 20.56 | 20.85 | 20.41 |
| OPM % | 23.17 | 17.03 | 22.53 | 34.38 | 31.31 | 41.82 | 46.78 | 44.05 | 39.1 | 37.04 |
| Other Income | 0.13 | 0.01 | 0.05 | 0.08 | 0.1 | 0.04 | 0.04 | 4.8 | 0.44 | 0.36 |
| Interest | 2.37 | 2.64 | 3.1 | 3.67 | 4.27 | 7.99 | 7.95 | 7.55 | 5.85 | 5.59 |
| Depreciation | 4.64 | 5.06 | 5.17 | 5.59 | 7.45 | 9.27 | 9.29 | 9.02 | 10.63 | 11.51 |
| Profit before tax | 4.01 | 1.82 | 4.25 | 8.62 | 4.47 | 4.62 | 4.06 | 8.79 | 4.81 | 3.67 |
| Tax % | 21.95 | -23.08 | -4.47 | 34.11 | 50.78 | 42.64 | 37.93 | 17.18 | 135.55 | — |
| Net Profit | 3.12 | 2.25 | 4.44 | 5.68 | 2.2 | 2.65 | 2.53 | 7.28 | -1.71 | -2.85 |
| EPS in Rs | 3.17 | 1.82 | 3.45 | 4.23 | 1.54 | 1.78 | 1.7 | 4.24 | -0.77 | -1.28 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 9.35 | 9.85 | 12.35 | 12.89 | 13.42 | 14.26 | 14.9 | 14.9 | 17.16 | 22.19 |
| Reserves | 3.22 | 9.46 | 14.92 | 20.14 | 29.11 | 32.87 | 36.97 | 39.5 | 60.74 | 70.97 |
| Borrowings | 27.06 | 25.12 | 21.68 | 24.37 | 30.96 | 67.44 | 62.39 | 73.06 | 54.03 | 67.38 |
| Other Liabilities | 11.49 | 15.08 | 6.37 | 6.29 | 6.03 | 7.91 | 8.77 | 9.67 | 11.3 | 17.89 |
| Total Liabilities | 51.12 | 59.51 | 55.32 | 63.69 | 79.52 | 122.48 | 123.03 | 137.13 | 143.23 | 178.43 |
| Fixed Assets | 28.57 | 27.66 | 30.01 | 34.99 | 52.05 | 95.17 | 88.87 | 80.37 | 88.24 | 123.02 |
| CWIP | 2.96 | 3.94 | 0.07 | 0.15 | 0.32 | 0.87 | 1.9 | 9.21 | 12.84 | 4.81 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.91 |
| Other Assets | 19.59 | 27.91 | 25.24 | 28.55 | 27.15 | 26.44 | 32.26 | 47.55 | 42.15 | 28.69 |
| Total Assets | 51.12 | 59.51 | 55.32 | 63.69 | 79.52 | 122.48 | 123.03 | 137.13 | 143.23 | 178.43 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -5.66 | 11.11 | -0.78 | 8.61 | 14.18 | 16.64 | 14.83 | 15.52 | 11.83 | — |
| Cash from Investing Activity | -11.84 | -4.72 | -3.53 | -10.23 | -22.82 | -51.11 | -4 | -7.95 | -15.84 | — |
| Cash from Financing Activity | 6.83 | -3.43 | 0.72 | 2.09 | 8.78 | 35.02 | -11.18 | -7.56 | 3.9 | — |
| Net Cash Flow | -10.67 | 2.96 | -3.59 | 0.47 | 0.14 | 0.55 | -0.34 | 0.01 | -0.11 | — |
| Free Cash Flow | -17.5 | 6.39 | -4.31 | -1.62 | -8.64 | -34.47 | 10.83 | 7.57 | -4.01 | — |
| CFO/OP | -70 | 110 | -13 | 68 | 96 | 118 | 77 | 80 | 65 | — |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 82.03 | 91.48 | 54.98 | 69.11 | 51.39 | 85.37 | 86.52 | 94.76 | 87.98 | 80.42 |
| Inventory Days | 204.47 | 289.48 | 255.75 | 451.13 | 672.29 | 312.99 | 429.7 | 831.44 | 491.08 | 365.9 |
| Days Payable | 242.14 | 304.36 | 152.08 | 166.72 | 70.37 | 74.02 | 50.68 | 100.49 | 61.78 | 88 |
| Cash Conversion Cycle | 44.36 | 76.61 | 158.65 | 353.52 | 653.31 | 324.35 | 465.53 | 825.71 | 517.29 | 358.32 |
| Working Capital Days | 19.25 | -13.28 | 36.22 | 35.15 | 28.76 | 8.1 | 38.09 | 63.76 | 100.26 | -22.24 |
| ROCE % | 12.37 | 15.18 | 9.55 | 13.82 | 18.78 | 9.29 | 11.02 | 9.94 | 9.04 | 7.29 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 42.08% | 42.08% | 42.08% | 42.08% | 42.08% | 38.88% | 40.85% | 39.06% | 35.16% | 35.16% | 35.43% | 30.62% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 23.43% | 23.52% | 25.35% | 26.11% | 26.51% | 35.03% | 34.74% | 34.39% | 32.3% | 32.7% | 32.37% | 32.52% |
| Others | 34.49% | 34.4% | 32.57% | 31.81% | 31.41% | 26.08% | 24.41% | 26.55% | 32.53% | 32.13% | 32.2% | 36.87% |
| No. of Shareholders | 13006 | 15615 | 18971 | 18852 | 19545 | 21167 | 21169 | 21896 | 21659 | 21622 | 21427 | 21224 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 5 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 18.33 | Sell |
| EMA (10) | 18.22 | Sell |
| SMA (20) | 18.62 | Sell |
| EMA (20) | 18.84 | Sell |
| SMA (50) | 20.92 | Sell |
| EMA (50) | 20.53 | Sell |
| SMA (100) | 23.33 | Sell |
| EMA (100) | 22.57 | Sell |
| SMA (200) | 25.74 | Sell |
| EMA (200) | 25.67 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 28.52 | Buy |
| MACD (12,26,9) | -0.87 | Sell |
| Stochastic (14,3,3) | 23.76 | Neutral |
| ADX (14) | 24.06 | Neutral |
| Williams %R (14) | -81.9 | Buy |
| ATR (14) | 1.22 | High Volatility |
| ROC (12) | -7.41 | Sell |
| Stoch RSI (14) | 21.18 | Neutral |
| UO (7,14,28) | 45.91 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Re-Lodgement Of Transfer Requests Of Physical Shares.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e7be7ca-14f1-4c3b-a34b-2ec73206e2bb.pdf) |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccba0090-9925-48cf-979e-f0c85421ca52.pdf) |
| 2026-09-09 | [Web Link Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2722c1b-d9cb-4ffd-8899-5773842ef11d.pdf) |
| 2026-09-08 | [39Th Annual General Meeting Notice.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66d5d72a-ee71-481c-93cf-ad594df26eb7.pdf) |
| 2026-09-08 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4333c2b9-8cfe-4ea3-95c9-25b43b9919d1.pdf) |
| 2026-08-26 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59c62bdd-05fa-4fa0-a00e-a991e10098f8.pdf) |
| 2026-08-24 | [Expiry Of Warrants](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4749cd5d-fc5a-44c8-8d4d-2a2d933d1840.pdf) |
| 2026-08-24 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=BEBC7E36_7452_414C_8F6D_CD0991A61665_101320.pdf) |
| 2026-08-24 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=593C6CB3_C55E_40C3_8E8F_BB70B023E1F2_101447.pdf) |
| 2026-08-24 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2247B732_072B_4A58_9069_5F61F141F0B8_101604.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-13 | [Submission Of Unaudited Standalone And Consolidated Financials Results For Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=413ef936-809e-404f-b918-1e09332f3acb.pdf) |
| 2026-05-30 | [Audited Standalone & Consolidated Financial Results For The Fourth Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a7f294e-afb2-410e-9aa6-9911b852004c.pdf) |
| 2026-02-13 | [Un-Audited Standalone & Consolidated Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=738a4513-b0c1-4bdd-83dc-f3edf89ab3cc.pdf) |
| 2025-11-14 | [Un-Audited Standalone & Consolidated Financial Results For The Quarter And Half-Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5058e603-e5b7-431a-a13c-0668c7dba46e.pdf) |
| 2025-08-12 | [For Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20355c59-3561-4ca9-91f6-8610aeccd055.pdf) |
| 2025-01-09 | [Third Quarter And Nine Months Ended December 31 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b695123-3971-4821-af36-6855a3b50a2d.pdf) |
| 2024-11-14 | [Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd265bbe-5c90-426b-98f5-c170b6067c63.pdf) |
| 2024-08-10 | [Unaudited Standalone And Consolidated Financial Results For The First Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e98b2e5-b17c-4947-b896-02a6a60b3c9c.pdf) |
| 2024-05-20 | [Results - Audited Standalone And Consolidated Financial Results For The Fourth Quarter And Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=faabe63c-f356-45cf-9009-02f0a5d55d41.pdf) |
| 2024-02-12 | [Un-Audited Financial Results For The Third Quarter And Nine Months Ended December 31, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=581825a6-d75c-4cbd-8ffa-d33bf1e5cb16.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Reported nil re-lodgement requests for physical share transfers in April 2026. | [Report On Re-Lodgement Of Transfer Requests Of Physical Shares 9h - Reported nil re-lodgement requests for physical share transfers in April 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/93b20832-66a6-4f2f-b3eb-c181840573bc.pdf) |
| 7 Dec 2023 - Board meeting to approve unaudited financial results. | [Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Half Year Ended On 30Th September, 2023 7 Dec 2023 - Board meeting to approve unaudited financial results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8c81143d-b2d6-4ca9-ab70-7a628cf5fad4.pdf) |
| 7 Apr - Filed Regulation 74(5) certificate for dematerialization period January 1 to March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Filed Regulation 74(5) certificate for dematerialization period January 1 to March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d7d791c4-3666-4837-ba3c-d0a69dd1ceb0.pdf) |
| 2 Feb - Board meeting Feb 13, 2026 to approve Q3 and nine-month unaudited results; trading window closed till Feb 15, 2026. | [Board Meeting Intimation for Meeting To Be Held On Friday, February 13, 2026 2 Feb - Board meeting Feb 13, 2026 to approve Q3 and nine-month unaudited results; trading window closed till Feb 15, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/01c6f77c-3f09-40c1-91f3-9aec7d4cda81.pdf) |
| 13 Feb - Unaudited Q3 & 9M results (Dec 31, 2025): standalone revenue Rs1,336.60L, PAT Rs125.83L; consolidated revenue Rs1,351.30L, PAT Rs124.81L | [Board Meeting Outcome for Un-Audited Standalone & Consolidated Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31, 2025 13 Feb - Unaudited Q3 & 9M results (Dec 31, 2025): standalone revenue Rs1,336.60L, PAT Rs125.83L; consolidated revenue Rs1,351.30L, PAT Rs124.81L](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6d6cde89-510d-456b-a2cc-8f758ba4a9df.pdf) |
| 13 Apr - Reported nil re-lodgement requests for physical shares in March 2026. | [Report On Re-Lodgement Of Transfer Requests Of Physical Shares 13 Apr - Reported nil re-lodgement requests for physical shares in March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/53d4bf80-b156-40b4-a5d4-c417fb79bca3.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Apr](https://www.bseindia.com/xml-data/corpfiling/AttachHis/254c6456-84e2-458b-afad-17187704a910.pdf) |
| — | [Closure of Trading Window 27 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/64fb330f-ec34-4eb0-80ce-435704c347cc.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3cc63bdc-3eb0-44f8-8b20-11a8cb69b9c4.pdf) |
| — | [Un-Audited Standalone & Consolidated Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31, 2025 13 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/738a4513-b0c1-4bdd-83dc-f3edf89ab3cc.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3aab3f6-e0c1-4745-93f5-3f8273b1a186.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/27265686-b198-4b80-b0b6-f93d4be8e488.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/491a9ab2-efcb-4f54-bb04-66609ed7a4f9.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/511509/76729511509.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/780019/70822780019.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/511509/71648511509.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/780019/68378780019.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/511509/66766511509_01_10_20.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/511509/5115090319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/780019/7800190318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:26:28.239Z.